Dopamine d2 Receptor Antikörper (3rd Cytoplasmic Domain)
-
- Target Alle Dopamine d2 Receptor (DRD2) Antikörper anzeigen
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
-
Bindungsspezifität
- 3rd Cytoplasmic Domain
-
Reaktivität
- Human, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Dopamine d2 Receptor Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- Reacts with human DRD2
- Kreuzreaktivität (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins, except ZNF57 (42 % ).
- Aufreinigung
- Antigen affinity purified
- Immunogen
- Synthetic 19 amino acid peptide from 3rd cytoplasmic domain of human DRD2. Percent identity with other species by BLAST analysis: Human, Chimpanzee, Gorilla, Marmoset (100%), Gibbon, Monkey, Rabbit (95%), Dog, Bovine, Panda, Horse, Pig (89%), Mouse, Rat, Ferret, Bat, Hamster, Elephant (84%)
- Isotyp
- IgG
- Top Product
- Discover our top product DRD2 Primärantikörper
-
anti-Dopamine Receptor D2 (DRD2) (AA 194-421) antibody
DRD2 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 201-300) antibodyDRD2 Reaktivität: Human, Ratte, Maus WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 1-110) antibodyDRD2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1B11 unconjugated
anti-Dopamine Receptor D2 (DRD2) (Cytoplasmic Domain) antibodyDRD2 Reaktivität: Human, Hund, Fledermaus, Rind (Kuh), Pferd, Kaninchen IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 307-336), (C-Term) antibodyDRD2 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) antibodyDRD2 Reaktivität: Hund WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 301-400) antibodyDRD2 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 201-300) antibody (AbBy Fluor® 488)DRD2 Reaktivität: Human, Ratte, Maus WB, IF (cc), IF (p) Wirt: Kaninchen Polyclonal AbBy Fluor® 488
anti-Dopamine Receptor D2 (DRD2) (AA 214-373) antibodyDRD2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 11-26), (Extracellular), (N-Term) antibodyDRD2 Reaktivität: Human, Ratte, Maus WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Working dilution: IHC - P (3 μg/mL - 4
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS, Sodium azide 0.1 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-80 °C
- Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
- Target
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
- Andere Bezeichnung
- Dopamine D2 Receptor (DRD2 Produkte)
- Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
-
